share_log
Reuters ·  May 1 08:30
Aileron Therapeutics Announces Positive Data From Cohort 1 of the Phase 1B Clinical Trial of Lti-03 in Idiopathic Pulmonary Fibrosis (Ipf)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment